Study identifies expression of tumor antigen as marker for aggressive ovarian cancer

[News]

Patients who expressed the tumor antigen NY-ESO-1 had more aggressive cancers and were more likely to die early from their disease, according to a large study conducted by Roswell Park Cancer Institute researchers and published online ahead of print in the journal Gynecologic Oncology.

More... (http://www.news-medical.net/news/20170426/Study-identifies-expression-of-tumor-antigen-as-marker-for-aggressive-ovarian-cancer.aspx)